This expansion will allow families in the United Kingdom, and the rest of Europe, to harvest and store stem cells from their children's baby teeth, which have the potential to treat a variety of diseases and injuries ranging from spinal-cord paralysis to bone and teeth regeneration to Alzheimer's to Parkinson's to Heart Disease and more. BioEDEN's U.K. state-of-the-art lab will utilize the same proprietary technology and methods used in its United States-based headquarters and will have direct access to the scientists who developed this revolutionary new process for stem cell extraction, storage and reanimation.

"Stem cell therapy has the potential to revolutionize the treatment of human disease. However, there has been strong and very powerful criticism of how stem cells are taken from the embryo or umbilical cord and this has had a massive impact in stifling progress in its development and use," said Dr. David James, BChD, CEO of BioEDEN Europe. "We have the ability to change that as a result of our BioEDEN process which is totally non-invasive and has no risks to the mother or child, and of course give tremendous health benefits to families for many years to come."

"The expansion of BioEDEN into Europe is a big step for our company and one we feel will greatly expand the availability of stem cell banking from baby teeth and the medical science surrounding stem cell therapies," said Jeff Johnson, president of BioEDEN, Inc. "Stem cells have already been used to treat diabetes, spinal paralysis and several other diseases and every day brings us one step closer to a time when physicians will actually cure disease rather than simply treat it."

"It can be described as 'biological insurance' for your family," says Dr. David James. "It makes sense to preserve these potentially life-saving cells for a child rather than discard them. BioEDEN is committed to making alternative medicine an affordable reality to everyone, and we're very pleased to now extend this service across all of Europe."

BioEDEN's proprietary process allows its scientists to harvest and grow stem cells in its lab where they are observed to insure they are sufficient in number and are viable enough to undergo the cryogenic process. If it is determined that the cells are not viable for therapeutic use BioEDEN allows the family to send another tooth at no additional charge.

About BioEden

BioEDEN Baby Tooth Cell Bank is a world-class, specialty stem cell processing company with state-of-the-art facilities located in the heart of Texas among the renowned medical research centers of Scott & White Hospital in Temple, Baylor College of Medicine in Houston and Southwestern Medical Center in Dallas.

BioEDEN Baby Tooth Cell Bank is the first company of its kind to isolate and store living stem cells from deciduous baby teeth and their laboratory personnel are expertly trained in the processing, propagation, and cryopreservation of these unique stem cells.

With world health care moving toward personalized medicine where treatment is customized for each individual, the use of stem cells found in children's primary teeth is a significant step forward. These cells are a viable, ethical, and morally non-controversial alternative to the possibilities offered by embryonic stem cells. At the forefront of this new technology, BioEDEN is the first tooth cell bank in the world to offer cellular isolation and storage services for these valuable tooth cells.

According to President Jeff Johnson, "Public interest in primary tooth stem cells is growing not only locally, but globally. As a private laboratory registered with the FDA, we maintain high standards required for FDA oversight. After a recent FDA review, we are now approved to accept teeth from our neighbors in Canada.

"A primary consideration in the use of tooth cell storage is the cost. At less than 1/3 the cost of cord blood storage, banking a child's primary tooth stem cells not only provides a guaranteed matching donor for life, it is simple and painless for both the child and parent, and it preserves the cells before natural damage occurs. There are only twelve teeth that contain these promising cells, and cell viability – determined by when a tooth is expelled -- reduces the longer a loose tooth remains in the mouth. A tooth collected shortly after it becomes loose is most viable, and is critical that we receive a tooth quickly after it falls out."

BioEDEN isolates and stores tooth cells, and returns them to the original donor if they are ever needed. Unlike cord blood banking, which is public, BioEDEN's customers are only given their own cells. This autologous banking system eliminates worry about communicable diseases, tissue rejection, or immunosuppressive therapy, and will contribute to successful therapies where it is imperative that the source of the stem cells be compatible with the recipient. BioEDEN also leads the industry in offering a complete guarantee.

The stem cells found in children's primary teeth are a viable, ethical, and morally non-controversial alternative to the possibilities offered by embryonic stem cells. BioEden, Inc. was founded to bring this exciting technology to the American public at an affordable price, and to allow for the promise of a better future. World health care is moving toward personalized medicine where treatment is customized for each individual, and the use of stem cells found in children's primary teeth to treat debilitating conditions is a significant step toward that goal.

According to President Jeff Johnson, the process is simple: "When your child's tooth begins to loosen, call us. We will send you a kit with processing instructions, and make arrangements to have the tooth transported to our facility in Austin, Texas where the cells contained in the tooth will be removed and stored in a special process that keeps them viable for the future.

"Stem cell research is the most promising path to curing many severe diseases and disabling medical conditions. For stem cell therapy to work, however, it is imperative that the source of the stem cells be compatible with the recipient. We are not a public cell bank like umbilical cord blood banks. We isolate and store cells and return them to the original donor if they are ever needed. This way you don't have to worry about communicable diseases, tissue rejection, or immunosuppressive therapy. You get your own cells back and nothing else." It is critical that the cells be extracted quickly after the tooth falls out, and there are only 12 teeth that can be used for this process -- not every tooth contains cells with this potential."

BioEden is registered with the FDA, and it is the first fully operational processing laboratory and storage bank for primary teeth stem cells to open in the U.S. Their state-of-the-art facilities are located in Austin, Texas, and will serve children and their families nationwide. BioEden is also the only cell storage facility willing to guarantee their services.

Dr. Songao Shi, who was at the time the Principle Investigator of the Dental Biology Unit at the National Institute of Health, identified adult stem cells in primary children's teeth in 2003. Progenitor cells discovered include adiposites, osteoblasts, chondracytes, and mesenchymal stem cells. These types of cells are all being investigated for their ability to therapeutically treat many human diseases including heart disease, bone regeneration, and most promisingly neuronal degenerative disorders such as Alzheimer's, Parkinson's, and spinal cord injury.